TickerFacts.

China SXT Pharmaceuticals, Inc. (SXTC): Revenue

Annual figures by period end, from SEC filings.

$1.14M
Year ended 2026-03-31
-16.7%
3-year compound annual growth
-24.9%
5-year compound annual growth
$7.02M2017-03-31: $4.88M2018-03-31: $7.02M2019-03-31: $7.01M2020-03-31: $5.16M2021-03-31: $4.78M2022-03-31: $2.60M2023-03-31: $1.97M2024-03-31: $1.93M2025-03-31: $1.74M2026-03-31: $1.14M$1.14M
2017-03-31 Revenue (USD) 2026-03-31
Period endedRevenueChange YoYSource filing
2026-03-31$1.14M-34.6%2026-07-01, From 2025-04-01
2025-03-31$1.74M-9.7%2026-07-01, From 2024-04-01
2024-03-31$1.93M-2.2%2026-07-01, From 2023-04-01
2023-03-31$1.97M-24.2%2025-07-31, From 2022-04-01
2022-03-31$2.60M-45.5%2024-08-13, From 2021-04-01
2021-03-31$4.78M-7.5%2023-07-31, From 2020-04-01
2020-03-31$5.16M-26.4%2023-05-19, From 2019-04-01
2019-03-31$7.01M-0.1%2021-08-13, From 2018-04-01
2018-03-31$7.02M+43.8%2020-07-31, From 2017-04-01
2017-03-31$4.88Mn/a2019-08-15, From 2016-04-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$1.14M-34.6%
Bespoke Extracts, Inc. (BSPK)2024-12-31$1.12M+42.3%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$1.17M-92.5%
Longeveron Inc. (LGVN)2025-12-31$1.20M-49.9%
Dare Bioscience, Inc. (DARE)2025-12-31$1.03Mn/m
Vistagen Therapeutics, Inc. (VTGN)2026-03-31$1.27M+161.1%
IGC Pharma, Inc. (IGC)2025-03-31$1.27M-5.5%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$1.01M+65.5%
Shattuck Labs, Inc. (STTK)2025-12-31$1.00M-82.5%

Compare SXTC, BSPK, NEUP, LGVN side by side · Screen every company in Pharmaceutical Preparations ↗